Ebv-positive Post-transplant Lymphoproliferative Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-02-20
Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]
This Phase 2 clinical trial update reports that the study evaluating Tabelecleucel for Epstein-Barr virus–associated diseases is currently r…